Literature DB >> 11184175

Can antitumor platinum compounds be effective against Candida albicans?--A screening assay using disk diffusion method.

K Chandrasekar, J H Shyla, R Malathi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11184175      PMCID: PMC87509     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  3 in total

1.  Candida catenulata fungemia in a cancer patient.

Authors:  M Radosavljevic; H Koenig; V Letscher-Bru; J Waller; F Maloisel; B Lioure; R Herbrecht
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

2.  Cisplatin inhibits synthesis of ribosomal RNA in vivo.

Authors:  P Jordan; M Carmo-Fonseca
Journal:  Nucleic Acids Res       Date:  1998-06-15       Impact factor: 16.971

3.  Fluconazole disk diffusion susceptibility testing of Candida species.

Authors:  W R Kirkpatrick; T M Turner; A W Fothergill; D I McCarthy; S W Redding; M G Rinaldi; T F Patterson
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  3 in total
  4 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  5-fluorouracil altered morphology and inhibited growth of Candida albicans.

Authors:  Chandrasekhar Kesavan; Antony George Joyee
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 3.  Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence of Candida and Aspergillus species.

Authors:  Sharon C-A Chen; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

4.  Morphological and growth altering effects of Cisplatin in C. albicans using fluorescence microscopy.

Authors:  Chandrasekhar Kesavan; Malathi Raghunathan; Natarajan Ganesan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2005-04-25       Impact factor: 3.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.